Chronic Migraine, Headache Clinical Trial
Official title:
Developing a Mobile Health Pain-Coping Skills Training Program for the Treatment of Chronic Migraine: Testing Feasibility, Acceptability, and Utility, AIM 4
This ClinicalTrials.gov record pertains only to the clinical trial described below in Aim 4. Aims 1-3 and 5 are described here as background information. This study will be a two-site collaborative research effort (Wake Forest & Duke Univ.) drawing on expertise of investigators steeped in PCST, Internet-based treatment delivery, and development of cost-efficient and maximally-accessible behavioral interventions for migraine and chronic pain. This research will address four specific aims via a mixed-methods approach. In Aim 1 subjects (n=20) will be recruited to participate in user testing of the extant program (PainCOACH1). In Aim 2 subjects (n=64, including migraineurs, members of migraine patient advocacy groups, and clinical professionals trained in headache medicine) will participate in focus groups to provide guidance for appropriately tailoring the program for the treatment of chronic migraine. In Aim 3 feedback from Aims 1 and 2 will be employed to build and develop PainCOACH Migraine which will be beta-tested and refined. In Aim 4 subjects (n=144) will be recruited to participate in a randomized, controlled trial of the PainCOACH Migraine program (versus Medical Treatment as Usual) to demonstrate its feasibility, acceptability and engagement, and promise. Guided by findings from these aims a final exploratory aim will be conducted to optimize the program using prediction models to identify patients at risk for poor outcomes or attrition, and an adaptive therapeutic process targeting improved outcomes for such patients. Ultimately these research efforts will provide data and experience needed to support a subsequent large-scale and methodologically rigorous adaptive trial to test PainCOACH Migraine and enhance understanding of the potentials for Internet-based delivery of behavioral programs for individuals with chronic migraine.
In addition to experiencing chronic pain, disability, and diminished quality of life, individuals with chronic migraine face critical access barriers to traditional, validated, clinic-based behavioral headache treatments (eg, availability of trained therapists, cost, absences from work). Internet-based and mHealth technologies show promise for the treatment of chronic pain conditions and are primed to address barriers to treatment, but have not yet been optimally translated into interventions for chronic migraine. A program of development is proposed to transform a validated, 8-week Internet-based pain-coping skills training (PCST) program (PainCOACH I; original) into a version specific for chronic migraine. PainCOACH I was designed to retain key therapeutic components of in-clinic protocols and includes 8 modules of self-directed, tailored, interactive training in cognitive behavioral pain coping skills. A "virtual coach" provides verbal and visual instruction, feedback, and encouragement guided by theoretically-based learning principles. PainCOACH I has been successfully tested for populations with osteoarthritis and cancer pain, and has been studied in the US and Australia. This clinical trial registration pertains only to Aim 4 of the study. In Aim 4 subjects (n=144) will be recruited to participate in a randomized, controlled trial of the PainCOACH Migraine program (versus Medical Treatment as Usual) to demonstrate its feasibility, acceptability and engagement, and promise. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Terminated |
NCT04520425 -
Osteopathic Manipulative Techniques for the Treatment of Chronic Migraine Headaches
|
N/A | |
Recruiting |
NCT06247592 -
Pulse Radiofrequency and Occipital Nerve Block for Chronic Migraine Patients
|
N/A | |
Recruiting |
NCT06133491 -
Open Label, 6-month Study for High Frequency and Chronic Migraine,
|
||
Recruiting |
NCT04989413 -
Cannabidiol 133mg + Cannabigerol 66mg + Tetrahydrocannabinol 4mg vs Placebo as Adjuvant Treatment in Chronic Migraine -
|
Phase 4 | |
Recruiting |
NCT06138171 -
Personality, Defences, Central Sensitization, and Trauma in Women With Chronic Migraine, Fibromyalgia, and Vulvodynia
|
||
Active, not recruiting |
NCT06109389 -
The Efficacy Of Lidocaine Infusion IN Chronic Unilateral Migraine Headache
|
Phase 2 | |
Completed |
NCT04871581 -
Adjunctive Treatment of Chronic Migraine Using an Oral Dental Device
|
N/A | |
Withdrawn |
NCT01749423 -
A Retrospective Study to Evaluate the Effectiveness of onabotulinumtoxinA in Preventing Headaches in Patients With Chronic Migraines
|
N/A | |
Terminated |
NCT04349176 -
Onabotulinum Dose Comparison in Chronic Migraine Superior to 100 Units?
|
Phase 3 | |
Completed |
NCT05381129 -
The Effect of Accompanying Temporomandibular Joint Dysfunction in Patients With Chronic Migraine
|
N/A | |
Completed |
NCT05381012 -
Fibromyalgia Syndrome on Patients With Chronic Migraine
|
N/A | |
Completed |
NCT03767062 -
Peripheral Nerve Block and Topiramate in the Treatment of Medication Overuse Headaches
|
N/A | |
Completed |
NCT05748535 -
Effect of Auricular Vagus Nerve Stimulation in Women With Migraine Disease
|
N/A | |
Recruiting |
NCT05724771 -
COACT Study: CGRPmAbs + OnabotulinumtoxinA Assessment of Chronic Migraine Treatments Study
|
Phase 4 | |
Recruiting |
NCT05313503 -
KETOMIGRAINE: Ketogenic Diet in Drug-resistant Chronic Migraineurs
|
N/A | |
Recruiting |
NCT05079659 -
Rate , Predictors and Outcome of Chronic Migraine
|
||
Completed |
NCT06118190 -
Mesotherapy in the Treatment of Chronic Migraine
|
N/A | |
Completed |
NCT03698409 -
Onabotulinumtoxin Type A Reconstitution With Preserved Versus Preservative-free Saline in Chronic Migraine.
|
Phase 4 | |
Completed |
NCT04017741 -
A Study Investigating the Efficacy of GON Blocks.
|
Phase 4 | |
Completed |
NCT05679908 -
A Study to Evaluate the Efficacy and Safety of TNX-1900 in Patients With Chronic Migraine
|
Phase 2 |